NURR1/NOT agonistinin Parkinson hastalığının tedavisinde potansiyel olarak yararlı olan bir dizi romanın sentezi, ADME ve farmakolojik özellikleri ve erken güvenlik farmakolojisi değerlendirmesi hakkında veriler.

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

This article describes the chemical synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel Nurr1/NOT agonist. It is meant as a support to an article recently published in Bioorganic and Medicinal chemistry Letters and entitled "Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease" [1] and presenting the discovery, scope and potential of these new ligands of these nuclear receptors.

İlgili konular